Strain Information | |
---|---|
Image | |
BRC No. | RBRC05228 |
Type | Transgene |
Species | Mus musculus |
Strain name | ICR;B6D2-Tg(CAG-Luc,Hsd17b3/EGFP)6Tysn |
Former Common name | ICR-CAG-Luc,Hsd17b3/EGFP Tg#6 |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Tsuyoshi Nakanishi, graduate school of pharmaceutical sciences, Osaka University in 2007. The transgene was injected into the pronuclei of B6D2F1 fertilized eggs. ICR mixed background. |
Strain description | These transgenic mice express a 17betaHSD type3 and GFP fusion protein by cre-mediated recombination. |
Colony maintenance | Carrier x Noncarrier [or Crossing to Slc:ICR] |
References |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter EGFPEnhanced Green Fluorescent Protein (Aequorea victoria)UNEGFP Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Hsd17b3hydroxysteroid (17-beta) dehydrogenase 3UNHsd17b3 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter loxPphage P1 loxPUNloxP Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter loxPphage P1 loxPUNloxP Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter lucluciferase (firefly)UNluc |
Ordering Information | |
---|---|
Donor DNA | Chicken beta-actin promoter, Cytomegalovirus Cytomegalovirus enhancer, Mouse 17beta-hydroxysteroiddehydrogenase type3, Firefly Luciferase, Jellyfish Enhanced green fluorescent protein (EGFP), P1 Phage loxP, SV40 Poly A signal |
Research application | |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. (will be announced) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Tsuyoshi Nakanishi (Gifu Pharmaceutical University) |
Strain Status | Frozen sperm |
Strain Availability | Recovery and QC required prior to distribution |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |